FINWIRES · TerminalLIVE
FINWIRES

RTX 'Strong Growth' Across Portfolio, Raytheon Upside Seen as Catalyst, RBC Says

-- RTX (RTX) shows "strong growth" across its balanced aerospace and defense portfolio, while its Raytheon upside remains a catalyst, RBC Capital Markets said Wednesday in a research note.

Noting the company's strong Q1 results, RBC said that Raytheon's 9% organic growth was "impressive," driven by higher volumes on the Patriot, GEM-T, Tomahawk, and Standard Missile family of munitions.

RTX raised its 2026 adjusted sales estimate by $500 million and adjusted earnings per share by $0.10 at the midpoints, RBC said, adding that the company now expects Raytheon to grow in high single digits, while maintaining the outlook for Collins and Pratt & Whitney.

The investment firm also noted that broader organic growth guidance of between 5% to 6% still appears conservative, though a meaningful portion of defense backlog upside is expected to materialize only from mid-2027 onward.

RBC reiterated its outperform rating with a $230 price target.

Shares of RTX were down nearly 4% in Wednesday trading.

Price: $180.15, Change: $-7.02, Percent Change: -3.75%

Related Articles

Sectors

Sector Update: Health Care

Health care stocks declined late Thursday afternoon, with the NYSE Health Care Index decreasing 0.2% and the State Street Health Care Select Sector SPDR ETF (XLV) fractionally lower.The iShares Biotechnology ETF (IBB) fell 1.8%.In corporate news, Grace Therapeutics (GRCE) shares tumbled 48% after it said the US Food and Drug Administration issued a complete response letter for its new drug application for GTx-104, an intravenous formulation of nimodipine for aneurysmal subarachnoid hemorrhage.

$GRCE
Sectors

Sector Update: Consumer

Consumer stocks were mixed late Thursday afternoon, with the State Street Consumer Staples Select Sector SPDR ETF (XLP) rising 1.8% and the State Street Consumer Discretionary Select Sector SPDR ETF (XLY) falling 1%.In corporate news, Comcast (CMCSA) reported higher-than-expected Q1 results as the media and connectivity giant benefited from the Milan Cortina Winter Olympics and Super Bowl LX. Its shares jumped past 8%.

$CMCSA
Australia

Vertiv Raises Outlook After Strong Q1 as Margins Improve, UBS Says

Vertiv Holdings (VRT) posted strong Q1 results and raised its full-year earnings outlook, signaling continued margin expansion and solid growth momentum, UBS Securities said Wednesday in a note.The company lifted its full-year adjusted earnings per share guidance to about $6.35 at the midpoint, 4% above consensus estimates, helped by 2% higher organic sales and an 80-basis-point improvement in adjusted operating margin, UBS said. The updated outlook implies incremental margins of 32%, up from 28% previously, the note said.Q1 operating results came in 10% ahead of expectations, driven largely by stronger margins, while revenue was slightly above estimates, UBS said. Organic sales growth was modestly below elevated expectations, attributed to timing rather than softer demand, the note said.The midpoint of Vertiv's Q2 EPS outlook at $1.40 is below the $1.43 consensus estimate, which may reflect initial conservatism from management, the note said.UBS has a buy rating on Vertiv stock with a price target of $370.Price: $315.79, Change: $+10.65, Percent Change: +3.49%

$VRT